WG
ENZ

Winton Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Winton Group’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-39,041
Closed -$138K – 1465
2021
Q3 		$138K Buy
39,041
+1,163
+3% +$3.88K 0.01% 1276
2021
Q2 		$120K Sell
37,878
-428
-1% -$1.35K 0.01% 1378
2021
Q1 		$132K Sell
38,306
-780
-2% -$2.43K 0.01% 1321
2020
Q4 		$98K Sell
39,086
-20,961
-35% -$45.6K 0.01% 1260
2020
Q3 		$127K Sell
60,047
-37,695
-39% -$89.6K ﹤0.01% 1382
2020
Q2 		$219K Buy
97,742
+47,790
+96% +$123K 0.01% 1344
2020
Q1 		$126K Buy
49,952
+4,520
+10% +$11.1K ﹤0.01% 1304
2019
Q4 		$119K Sell
45,432
-4,173
-8% -$12.5K ﹤0.01% 1478
2019
Q3 		$179K Buy
+49,605
New +$176K ﹤0.01% 1408

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group's ENZ Position: Q4 2021 in Review

Winton Group sold out of Enzo Biochem, Inc. (ENZ) in Q4 2021, closing a stake of 39,041 shares — an estimated $138K sold.

Winton Group first reported a position in ENZ in Q3 2019 and held it in 9 quarters. The position peaked at $219K in Q2 2020. 59 funds tracked by Wall St. Rank hold ENZ as of Q4 2021.

  • Winton Group reported no remaining Enzo Biochem, Inc. position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 39,041 Enzo Biochem, Inc. shares in Q4 2021, an estimated $138K.
  • Winton Group first reported a position in Enzo Biochem, Inc. in Q3 2019 and held it in 9 quarters.
  • Winton Group's Enzo Biochem, Inc. position peaked at $219K in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.